Opus Genetics (IRD) Net Cash Flow (QoQ) (2010 - 2026)
Opus Genetics (IRD) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Opus Genetics |
355.39 Mn |
295.43 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
4.15% |
| Dec 31, 2025 |
984.51% |
| Sep 30, 2025 |
82.76% |
| Jun 30, 2025 |
-181.62% |
| Mar 31, 2025 |
281.76% |
| Dec 31, 2024 |
-32.11% |
| Sep 30, 2024 |
16.95% |
| Jun 30, 2024 |
-72.22% |
| Mar 31, 2024 |
-140.98% |
| Dec 31, 2023 |
243.49% |
| Sep 30, 2023 |
139.94% |
| Jun 30, 2023 |
127.13% |
| Mar 31, 2023 |
-112.67% |
| Dec 31, 2022 |
1,007.85% |
| Sep 30, 2022 |
-42.73% |
| Jun 30, 2022 |
58.00% |
| Mar 31, 2022 |
-331.52% |
| Dec 31, 2021 |
215.12% |
| Sep 30, 2021 |
-114.55% |
| Jun 30, 2021 |
335.04% |
